Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
The simultaneous activation of GIP and GLP-1 receptors may have central synergistic effects on appetite control, greater than selective GLP-1 receptor agonists [55], although preliminary studies do not support this hypothesis [56]
Protocol Quick-Reference PRECLINICAL ONLY: NNMT inhibition research compound Dosing Amount No established human dose (mouse: ~34 mg/kg/day SC) Frequency No established human frequency Duration No established human duration Administration Route Oral Schedule N/A (preclinical compound) Timing NO HUMAN DOSING DATA EXISTS
Waiting for patch test results before initiating treatment could prolong disease burden, reduce QoL and increase the risk of chronicity
BPC-157 (short for Body Protection Compound-157) is a non-natural compound derived from a naturally occurring protein from human gastric juice
US$ 24.45
US$ 20.12
US$ 20.98
US$ 28.92
US$ 28.42
US$ 21.14
US$ 20.96
US$ 19.99